Drug Delivery

European pharmaceutical company selects provider to develop metered dose inhaler

Published in Medical Devices and Surgical Technology Week, January 1st, 2006

Inyx, Inc., (IYXI) announced that its wholly owned subsidiary, Inyx Pharma Limited, has been selected by a European pharmaceutical company to develop a combination between a corticosteroid and a beta-2-agonist in a single metered dose inhaler (MDI) using a non-ozone-depleting hydrofluoroalkane (HFA) propellant.

Corticosteroids are the most effective and widely used anti-inflammatory drugs for the treatment of bronchial asthma and other chronic obstructive pulmonary diseases (COPD), such as bronchitis and emphysema. They are often taken with short-acting or long-acting bronchodilators (beta-2-agonists) that are the primary rescue medicine used to treat asthma and other...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week

Source: Medical Devices and Surgical Technology Week (2006-01-01)

More Articles from Medical Devices and Surgical Technology Week

Diagnostics
Indium pentetreotide imaging highly useful in diagnosing neuroendocrine tumors
Genetics & Genomics
Microarray-based system devised for multiplex amplifiable probe hybridization
Medical Devices
Olympus XCF-Q160AW prototype facilitates flexure passage
Medical Devices
Self-expanding nitinol stent treatment feasible; embolic protection device lowers stroke risk
Surgical Technology
SurgAssist computerized surgical stapling system shows promise
Acoustic Neuromas
New procedure allows those suffering from a specialized brain tumor to preserve their hearing
More from this issue of Medical Devices and Surgical Technology Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry